Help us make responsible and inclusive cannabis legislation possible for all Texans.

Regulatory

The Latest Report from the FDA Shows How Poorly It Has Handled CBD

On Wednesday, July 8, the Food and Drug Administration (FDA) sent Congress a report on the CBD marketplace. Last year, Congress mandated that the FDA report on hemp-derived CBD in appropriations legislation. You can find the report linked at the bottom of this article from Marijuana Moment, which also provides an overview of the report. […]

The Latest Report from the FDA Shows How Poorly It Has Handled CBD Read More »

Cannabis Banking: State Treasurers Ask Congress to Include SAFE Act in COVID-19 Relief Legislation

On Wednesday, July 8, 2020, a bipartisan group of sixteen state treasurers, led by Oregon Treasurer Tobias Read, sent a letter to congressional leaders requesting that the next piece of COVID-19 relief legislation include the SAFE Banking Act. The letter prominently cites both the well-known and new safety issues that come into play when forcing

Cannabis Banking: State Treasurers Ask Congress to Include SAFE Act in COVID-19 Relief Legislation Read More »

International Cannabis: Guidance for Companies Entering the U.S. Market, Part 4 –  Geography Matters

In prior blog posts (see here, here, and here), I described how we field regular inquiries regarding international cannabis, both from companies inside the U.S. looking internationally and from international companies looking to the U.S. market. This post deals with geography issues for international companies seeking to enter the U.S. market. Where to locate your

International Cannabis: Guidance for Companies Entering the U.S. Market, Part 4 –  Geography Matters Read More »

FREE Webinar Tomorrow: Ketamine, Psilocybin and New Drug Therapies

Register HERE for tomorrow’s FREE webinar! For the last 10 years, Harris Bricken attorneys have counseled countless domestic and international businesses and entrepreneurs on rapidly evolving laws and regulations in the cannabis, hemp, and cannabidiol (CBD) industries. As the legal and regulatory frameworks of those industries begin to solidify, new opportunities are emerging for the

FREE Webinar Tomorrow: Ketamine, Psilocybin and New Drug Therapies Read More »

ICYMI: The New FinCEN Hemp Banking Guidance

Last week, the Financial Crimes Enforcement Network (FinCEN), issued new guidance (the “FinCEN Guidance”) for financial institutions working with hemp-related businesses. The FinCEN Guidance centers on due diligence requirements as related to the Bank Secrecy Act (BSA). This guidance follows closely on the new National Credit Union Administration (NCUA) guidance for federally-chartered credit unions, which

ICYMI: The New FinCEN Hemp Banking Guidance Read More »

Hemp-CBD: More Federal Courts Stay CBD Cases Until the FDA Issues Regulations

In January, my colleague, Jesse Mondry, wrote about Snyder v. Green Roads of Florida, a case in which the U.S. District Court for the Southern District of Florida stayed a class action lawsuit against a cannabidiol (“CBD”) company until the Food and Drug Administration (“FDA”) forges a legal path for the manufacture, sale and marketing

Hemp-CBD: More Federal Courts Stay CBD Cases Until the FDA Issues Regulations Read More »

Donate to the cause

Help us make responsible and inclusive cannabis legislation possible for all Texans.